Diagnosing and Managing Polypoidal Choroidal Vasculopathy - Poll - MDSpire

Diagnosing and Managing Polypoidal Choroidal Vasculopathy

Polypoidal choroidal vasculopathy (PCV) is a distinct choroidal vascular disorder often considered a variant of age-related macular degeneration (AMD), although features such as drusen, pigmentary changes, and geographic atrophy are uncommon.

  • By

  • Giulia Gregori, MD

  • Jay Chhablani, MD

  • March 1, 2026

  • 9 min

Share

Original Source(s)

Diagnosing and Managing Polypoidal Choroidal Vasculopathy

  • by Giulia Gregori, MD, Jay Chhablani, MD

  • March 1, 2026

Related Content

Racing Toward Efficient AI Workflows

At the Focus A-Eye Summit, in the session “Lessons from Formula One: Optimizing Clinical Workflow with AI,” experts examined how artificial intelligence can streamline and accelerate ophthalmic clinical workflows.

Evaluation of the safety and neuroprotective properties of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo investigation

Early Fluid Resolution Predicts Faricimab Durability

Post hoc analysis suggests rapid retinal fluid resolution may help identify patients with nAMD who can maintain longer faricimab dosing intervals.